Is rituximab effective for systemic sclerosis? A systematic review and meta-analysis

Background: Systemic sclerosis (SSc) is a clinically complex and challenging disease, that leads to skin fibrosis. Its most frequent complication is interstitial lung disease (ILD), which leads to a worse prognosis. In this situation, cyclophosphamide is considered the gold standard for its treatm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Piuvezam, Grasiela, Caldas, Marina Maria Vieira de Figueiredo, Azevedo, Kesley Pablo Morais de, Nunes, Ana Clara de França, Oliveira, Victor Hugo de, Pimenta, Isac Davidson Santiago Fernandes, Araújo, Isabela Dantas Torres de, Bezerra Neto, Francisco Alves, Oliveira, Ana Katherine da Silveira Gonçalves de
Outros Autores: https://orcid.org/0000-0002-2343-7251
Formato: article
Idioma:English
Publicado em: Springer
Assuntos:
systemic sclerosis
rituximab
interstitial lung disease
cutaneous fibrosis
systematic review
Endereço do item:https://repositorio.ufrn.br/handle/123456789/55307
http://dx.doi.org/10.1186/s42358-021-00170-y.
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

https://repositorio.ufrn.br/handle/123456789/55307
http://dx.doi.org/10.1186/s42358-021-00170-y.

Registros relacionados